Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol

M. Rosenkranz, A. O'Donnell, U. Verthein, H. Zurhold, M. Addison, N. Liebregts, M. Rowicka, M. Barták, B. Petruželka, EF. Kaner, MS. Martens,

. 2019 ; 9 (8) : e029476. [pub] 20190810

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

INTRODUCTION: Amphetamine-type stimulants (ATS) including amphetamine, methylenedioxymethamphetamine/'ecstasy', methamphetamine, synthetic cathinones and 'Ritalin' are the second most commonly used illicit drugs globally. Yet, there is little evidence on which factors are associated with the development of different patterns of ATS use over the life course. This study aims to examine which individual, social and environmental factors shape different pathways and trajectories of ATS consumption. The study will be conducted in five European countries: Germany, the Netherlands, Poland, Czech Republic and the UK. METHODS AND ANALYSIS: We will use a sequential mixed-methods study design to investigate the multiple factors (familial, social and occupational situation, critical life events, general risk behaviour, mental and physical health, satisfaction with life) that shape individual ATS use pathways. A systematic literature review will be performed to provide an overview of the current academic literature on the topic. In module 1, qualitative semistructured interviews (n=ATS users and non-users) will be conducted to explore individual experiences of, and perspectives on, dynamics of change in stimulant consumption patterns. In module 2, structured questionnaires (n=2000 ATS users and non-users) will be administered via tablet computers to validate and enhance the generalisability of the interview findings. Data integration will take place at two key points. First, during the study, where the findings from the first qualitative interviews will inform the design of the structured questionnaire. Second, at the end of the study, where mixed methods data will be brought together to generate an in-depth, contextualised understanding of the research topic. ETHICS AND DISSEMINATION: The study has been approved by the respective responsible ethics committee in each participating country. Data will be treated confidentially to ensure participants' anonymity. Findings will be disseminated in peer-reviewed scientific journals, national and international conferences, and in briefings for policy and practice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025718
003      
CZ-PrNML
005      
20201222154046.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2019-029476 $2 doi
035    __
$a (PubMed)31401601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rosenkranz, Moritz $u Centre of Interdisciplinary Addiction Research of Hamburg University, Department of Psychiatry, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany moritz.rosenkranz@uni-hamburg.de.
245    10
$a Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol / $c M. Rosenkranz, A. O'Donnell, U. Verthein, H. Zurhold, M. Addison, N. Liebregts, M. Rowicka, M. Barták, B. Petruželka, EF. Kaner, MS. Martens,
520    9_
$a INTRODUCTION: Amphetamine-type stimulants (ATS) including amphetamine, methylenedioxymethamphetamine/'ecstasy', methamphetamine, synthetic cathinones and 'Ritalin' are the second most commonly used illicit drugs globally. Yet, there is little evidence on which factors are associated with the development of different patterns of ATS use over the life course. This study aims to examine which individual, social and environmental factors shape different pathways and trajectories of ATS consumption. The study will be conducted in five European countries: Germany, the Netherlands, Poland, Czech Republic and the UK. METHODS AND ANALYSIS: We will use a sequential mixed-methods study design to investigate the multiple factors (familial, social and occupational situation, critical life events, general risk behaviour, mental and physical health, satisfaction with life) that shape individual ATS use pathways. A systematic literature review will be performed to provide an overview of the current academic literature on the topic. In module 1, qualitative semistructured interviews (n=ATS users and non-users) will be conducted to explore individual experiences of, and perspectives on, dynamics of change in stimulant consumption patterns. In module 2, structured questionnaires (n=2000 ATS users and non-users) will be administered via tablet computers to validate and enhance the generalisability of the interview findings. Data integration will take place at two key points. First, during the study, where the findings from the first qualitative interviews will inform the design of the structured questionnaire. Second, at the end of the study, where mixed methods data will be brought together to generate an in-depth, contextualised understanding of the research topic. ETHICS AND DISSEMINATION: The study has been approved by the respective responsible ethics committee in each participating country. Data will be treated confidentially to ensure participants' anonymity. Findings will be disseminated in peer-reviewed scientific journals, national and international conferences, and in briefings for policy and practice.
650    _2
$a stimulanty centrálního nervového systému $x aplikace a dávkování $7 D000697
650    _2
$a lidé $7 D006801
650    _2
$a multicentrické studie jako téma $7 D015337
650    12
$a výzkumný projekt $7 D012107
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $x psychologie $7 D019966
650    _2
$a systematický přehled jako téma $7 D000078202
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a O'Donnell, Amy $u Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
700    1_
$a Verthein, Uwe $u Centre of Interdisciplinary Addiction Research of Hamburg University, Department of Psychiatry, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Zurhold, Heike $u Centre of Interdisciplinary Addiction Research of Hamburg University, Department of Psychiatry, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Addison, Michelle $u Department of Social Sciences, Northumbria University, Newcastle upon Tyne, UK.
700    1_
$a Liebregts, Nienke $u Bonger Institute of Criminology, University of Amsterdam, Amsterdam, The Netherlands.
700    1_
$a Rowicka, Magdalena $u Maria Grzegorzewska Academy of Special Education, Institute of Applied Psychology, Warsaw, Poland.
700    1_
$a Barták, Miroslav $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Petruželka, Benjamin $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Kaner, Eileen Fs $u Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
700    1_
$a Martens, Marcus-Sebastian $u Centre of Interdisciplinary Addiction Research of Hamburg University, Department of Psychiatry, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 9, č. 8 (2019), s. e029476
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31401601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154041 $b ABA008
999    __
$a ok $b bmc $g 1599863 $s 1116404
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 8 $d e029476 $e 20190810 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...